Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Belinchón, Isabel
209  Ergebnisse:
Personensuche X
?
1

Dose reduction is a feasible strategy in patients with plaq..:

Daudén, Esteban ; Escario, Elena ; Martos‐Cabrera, Luisa...
International Journal of Dermatology.  63 (2024)  4 - p. 503-511 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Psoriasis dermatitis, a common phenotype of early forms of ..:

Docampo‐Simón, Alexandre ; Belinchón, Isabel ; Sánchez‐Pujol, María J....
International Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

Safety of biologic therapy in combination with methotrexate..:

Lluch-Galcerá, Juan José ; Carrascosa, Jose Manuel ; González-Quesada, Alicia...
British Journal of Dermatology.  190 (2023)  3 - p. 355-363 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Multiple cutaneous T‐cell pseudolymphomas induced by acryla..:

Miñarro, Ángela María García ; Juan‐Carpena, Gloria ; Paz, Laura Taboada...
Contact Dermatitis.  88 (2022)  2 - p. 166-168 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Drug survival of adalimumab biosimilars in real‐world treat..:

López‐Ferrer, Anna ; Vilarrasa, Eva ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  11 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
6

Secukinumab is effective in the treatment of recalcitrant p..:

Reolid, Alejandra ; Armesto, Susana ; Sahuquillo-Torralba, Antonio...
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. 705-709 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Fast and sustained improvement of patient‐reported outcomes..:

Chicharro, Pablo ; Llamas‐Velasco, Mar ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  8 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
8

High adherence to secukinumab in patients with moderate to ..:

Martos‐Cabrera, Luisa ; Llamas‐Velasco, Mar ; Armesto, Susana...
International Journal of Dermatology.  62 (2022)  3 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
9

Secukinumab is effective and safe in the long‐term treatmen..:

Chicharro, Pablo ; Llamas‐Velasco, Mar ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  12 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
10

Multicenter Retrospective Study of Secukinumab Drug Surviva..:

Daudén, Esteban ; de Lima, Glauber Pacelli Gomes ; Armesto, Susana...
Dermatology and Therapy.  11 (2021)  6 - p. 2207-2215 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Psoriatic arthritis screening: A systematic literature revi..:

Urruticoechea-Arana, Ana ; Benavent, Diego ; León, Fernando...
PLOS ONE.  16 (2021)  3 - p. e0248571 , 2021
Link: https://doi.org/10.1371/..
 
?
12

Incidence of severe COVID-19 outcomes in psoriatic patients..:

Baniandrés-Rodríguez, Ofelia ; Vilar-Alejo, Jaime ; Rivera, Raquel...
Journal of the American Academy of Dermatology.  84 (2021)  2 - p. 513-517 , 2021
Link: https://doi.org/10.1016/..
 
?
13

A New Classification of the Severity of Psoriasis: What's M..:

Salgado-Boquete, Laura ; Carrascosa, José Manuel ; Llamas-Velasco, Mar...
Life.  11 (2021)  7 - p. 627 , 2021
Link: https://doi.org/10.3390/..
 
?
14

The risk of urinary tract infections in patients with psori..:

Sahuquillo-Torralba, Antonio ; Carretero, Gregorio ; Rivera, Raquel...
Journal of the American Academy of Dermatology.  82 (2020)  3 - p. 738-741 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Long-term safety of nine systemic medications for psoriasis..:

Daudén, Esteban ; Carretero, Gregorio ; Rivera, Raquel...
Journal of the American Academy of Dermatology.  83 (2020)  1 - p. 139-150 , 2020
Link: https://doi.org/10.1016/..
 
1-15